Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anastasios G. Konstas, Leopold Schmetterer, Vital P. Costa, Gábor Holló, Andreas Katsanos, Philippe Denis, Luciano Quaranta, Murat Irkec, Miguel A. Castejón, Miguel A. Teus & Alan L. Robin. (2020) Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review. Expert Opinion on Drug Safety 19:11, pages 1445-1460.
Read now
Read now
Lindsay Machen, Reza Razeghinejad & Jonathan S. Myers. (2020) Fixed-combination topical anti-hypertensive ophthalmic agents. Expert Opinion on Pharmacotherapy 21:10, pages 1269-1282.
Read now
Read now
S Fabián Lerner, Francesco Oddone, Da-Wen Lu, Ana Sanseau, Merce Guarro, Antonia Ridolfi & Douglas Hubatsch. (2019) Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension. Clinical Ophthalmology 13, pages 2411-2419.
Read now
Read now
Sourabh Sharma, Sameer Trikha, Shamira A Perera & Tin Aung. (2015) Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension. Clinical Ophthalmology 9, pages 2201-2207.
Read now
Read now
Quang H Nguyen. (2014) Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus. Patient Preference and Adherence 8, pages 853-864.
Read now
Read now
Sky K Chew, Simon E Skalicky & Ivan Goldberg. (2014) Brinzolamide plus brimonidine for the treatment of glaucoma: an update. Expert Opinion on Pharmacotherapy 15:16, pages 2461-2471.
Read now
Read now
Articles from other publishers (17)
Ryota Aoki, Etsuko Terao, Saki Dote, Miku Shiraishi, Satomi Oogi, Kanae Ueda, Yui Kimura, Yuki Nagata & Shunsuke Nakakura. (2022) Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients. BMJ Open Ophthalmology 7:1, pages e001200.
Crossref
Crossref
Sapna Sinha, Wesam Shamseldin Shalaby, Wendy W. Liu, Reza Razeghinejad & L. Jay Katz. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
612
661
.
Yara P. Catoira-Boyle, Darrell WuDunn, Louis B. Cantor, John T. Lind, Elizabeth Ann Martin & Steve L. Gerber. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
2331
2399
.
Jin A Kim & Heeyoung Lee. (2021) Effectiveness and Safety Verification of Brinzolamide Combination Therapy on Primary Open-angle Glaucoma or Ocular Hypertension: A Systematic Review and Meta-analysis Study. Korean Journal of Clinical Pharmacy 31:3, pages 205-215.
Crossref
Crossref
P S Rastogi, Kanupriya Jain, Ashish Chander & Munavvar Ansari. (2021) A comparative study of topical fixed dose combination of brimonidine (0.2%) plus brinzolamide (1%) versus brimonidine (0.2%) plus timolol (0.5%) in patients of primary open angle glaucoma. Indian Journal of Clinical and Experimental Ophthalmology 7:1, pages 112-117.
Crossref
Crossref
Sang Woo Park, Joon Mo Kim, Ji Woong Lee, Joy Maglambayan, Susan Simonyi & Ki Ho Park. (2021) Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma. Japanese Journal of Ophthalmology 65:2, pages 295-305.
Crossref
Crossref
In Ki Park, Seon Ha Bae, Kyoung Woo Kim & Yeoun Sook Chun. (2020) Clinical Characteristics of Allergy to a Brinzolamide 1.0%/Brimonidine 0.2% Fixed Combination in Korean Glaucoma Patients. Journal of the Korean Ophthalmological Society 61:9, pages 1065-1071.
Crossref
Crossref
Péter Kóthy & Gábor Holló. (2019) Real-life experience of using brinzolamide/brimonidine fixed drop combination in a tertiary glaucoma centre. International Ophthalmology 40:2, pages 377-383.
Crossref
Crossref
Yara P. Catoira-Boyle, Darrell WuDunn, Louis B. Cantor, John T. Lind, Elizabeth Ann Martin & Steve L. Gerber. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
1
69
.
Yuanzhi Liu, Junyi Zhao, Xiaoyan Zhong, Qiming Wei & Yilan Huang. (2019) Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 10.
Crossref
Crossref
Reza Moosavi & Ejaz Ansari. (2018) Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens. Ophthalmology and Therapy 7:2, pages 397-403.
Crossref
Crossref
In Tae KimJeong Hun BaeJoon Mo Kim. (2018) Clinical Effectiveness of a Brinzolamide 1%-Brimonidine 0.2% Fixed Combination for Normal Tension Glaucoma in South Koreans. Journal of the Korean Ophthalmological Society 59:6, pages 561.
Crossref
Crossref
R D Fechtner, J S Myers, D A Hubatsch, D L Budenz & H B DuBiner. (2016) Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial. Eye 30:10, pages 1343-1350.
Crossref
Crossref
Robert M. Feldman, Gregory Katz, Matthew McMenemy, Douglas A. Hubatsch & Tony Realini. (2016) A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004%. American Journal of Ophthalmology 165, pages 188-197.
Crossref
Crossref
Sarah L. Greig & Emma D. Deeks. (2015) Brinzolamide/Brimonidine: A Review of Its Use in Patients with Open-Angle Glaucoma or Ocular Hypertension. Drugs & Aging 32:3, pages 251-260.
Crossref
Crossref
Tin Aung, Guna Laganovska, Tania Josefina Hernandez Paredes, James D. Branch, Alexis Tsorbatzoglou & Ivan Goldberg. (2014) Twice-Daily Brinzolamide/Brimonidine Fixed Combination versus Brinzolamide or Brimonidine in Open-Angle Glaucoma or Ocular Hypertension. Ophthalmology 121:12, pages 2348-2355.
Crossref
Crossref
Stefano A. Gandolfi, John Lim, Ana Cristina Sanseau, Juan Camilo Parra Restrepo & Thomas Hamacher. (2014) Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension. Advances in Therapy 31:12, pages 1213-1227.
Crossref
Crossref